417 related articles for article (PubMed ID: 28386132)
21. Activation and Kinetics of Circulating T Follicular Helper Cells, Specific Plasmablast Response, and Development of Neutralizing Antibodies following Yellow Fever Virus Vaccination.
Sandberg JT; Ols S; Löfling M; Varnaitė R; Lindgren G; Nilsson O; Rombo L; Kalén M; Loré K; Blom K; Ljunggren HG
J Immunol; 2021 Aug; 207(4):1033-1043. PubMed ID: 34321231
[TBL] [Abstract][Full Text] [Related]
22. A Systematic, Unbiased Mapping of CD8
Stryhn A; Kongsgaard M; Rasmussen M; Harndahl MN; Østerbye T; Bassi MR; Thybo S; Gabriel M; Hansen MB; Nielsen M; Christensen JP; Randrup Thomsen A; Buus S
Front Immunol; 2020; 11():1836. PubMed ID: 32983097
[TBL] [Abstract][Full Text] [Related]
23. Dynamics of the CD8 T-cell response following yellow fever virus 17D immunization.
Co MD; Kilpatrick ED; Rothman AL
Immunology; 2009 Sep; 128(1 Suppl):e718-27. PubMed ID: 19740333
[TBL] [Abstract][Full Text] [Related]
24. A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice.
Kum DB; Boudewijns R; Ma J; Mishra N; Schols D; Neyts J; Dallmeier K
Emerg Microbes Infect; 2020; 9(1):520-533. PubMed ID: 32116148
[TBL] [Abstract][Full Text] [Related]
25. Long-lasting stem cell-like memory CD8+ T cells with a naïve-like profile upon yellow fever vaccination.
Fuertes Marraco SA; Soneson C; Cagnon L; Gannon PO; Allard M; Abed Maillard S; Montandon N; Rufer N; Waldvogel S; Delorenzi M; Speiser DE
Sci Transl Med; 2015 Apr; 7(282):282ra48. PubMed ID: 25855494
[TBL] [Abstract][Full Text] [Related]
26. Temporal dynamics of the primary human T cell response to yellow fever virus 17D as it matures from an effector- to a memory-type response.
Blom K; Braun M; Ivarsson MA; Gonzalez VD; Falconer K; Moll M; Ljunggren HG; Michaëlsson J; Sandberg JK
J Immunol; 2013 Mar; 190(5):2150-8. PubMed ID: 23338234
[TBL] [Abstract][Full Text] [Related]
27. Distinctive TLR7 signaling, type I IFN production, and attenuated innate and adaptive immune responses to yellow fever virus in a primate reservoir host.
Mandl JN; Akondy R; Lawson B; Kozyr N; Staprans SI; Ahmed R; Feinberg MB
J Immunol; 2011 Jun; 186(11):6406-16. PubMed ID: 21515797
[TBL] [Abstract][Full Text] [Related]
28. A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination.
Wieten RW; Jonker EF; van Leeuwen EM; Remmerswaal EB; Ten Berge IJ; de Visser AW; van Genderen PJ; Goorhuis A; Visser LG; Grobusch MP; de Bree GJ
PLoS One; 2016; 11(3):e0149871. PubMed ID: 26977808
[TBL] [Abstract][Full Text] [Related]
29. Multi-parameter approach to evaluate the timing of memory status after 17DD-YF primary vaccination.
Costa-Pereira C; Campi-Azevedo AC; Coelho-Dos-Reis JG; Peruhype-Magalhães V; Araújo MSS; do Vale Antonelli LR; Fonseca CT; Lemos JA; Malaquias LCC; de Souza Gomes M; Rodrigues Amaral L; Rios M; Chancey C; Persi HR; Pereira JM; de Sousa Maia ML; Freire MDS; Martins RM; Homma A; Simões M; Yamamura AY; Farias RHG; Romano APM; Domingues CM; Tauil PL; Vasconcelos PFC; Caldas IR; Camacho LA; Teixeira-Carvalho A; Martins-Filho OA
PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006462. PubMed ID: 29879134
[TBL] [Abstract][Full Text] [Related]
30. A qualitatively validated mathematical-computational model of the immune response to the yellow fever vaccine.
Bonin CRB; Fernandes GC; Dos Santos RW; Lobosco M
BMC Immunol; 2018 May; 19(1):15. PubMed ID: 29801432
[TBL] [Abstract][Full Text] [Related]
31. Duration of post-vaccination humoral immunity against yellow fever in children.
de Noronha TG; de Lourdes de Sousa Maia M; Geraldo Leite Ribeiro J; Campos Lemos JA; Maria Barbosa de Lima S; Martins-Filho OA; Campi-Azevedo AC; da Silva Freire M; de Menezes Martins R; Bastos Camacho LA;
Vaccine; 2019 Nov; 37(48):7147-7154. PubMed ID: 31590934
[TBL] [Abstract][Full Text] [Related]
32. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans.
Schulz AR; Mälzer JN; Domingo C; Jürchott K; Grützkau A; Babel N; Nienen M; Jelinek T; Niedrig M; Thiel A
J Immunol; 2015 Nov; 195(10):4699-711. PubMed ID: 26459351
[TBL] [Abstract][Full Text] [Related]
33. Cynomolgus macaques as a translational model of human immune responses to yellow fever 17D vaccination.
Mantel N; Piras-Douce F; Chautard E; Marcos-Lopez E; Bodinham CL; Cosma A; Courtois V; Dhooge N; Gautheron S; Kaufmann SHE; Pizzoferro K; Lewis DJM; Martinon F; Pagnon A; Raynal F; Dereuddre-Bosquet N; Le Grand R
J Virol; 2024 May; 98(5):e0151623. PubMed ID: 38567951
[TBL] [Abstract][Full Text] [Related]
34. Protein structure shapes immunodominance in the CD4 T cell response to yellow fever vaccination.
Koblischke M; Mackroth MS; Schwaiger J; Fae I; Fischer G; Stiasny K; Heinz FX; Aberle JH
Sci Rep; 2017 Aug; 7(1):8907. PubMed ID: 28827760
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity and duration of protection after yellow fever vaccine in people living with human immunodeficiency virus: a systematic review.
Martin C; Domingo C; Bottieau E; Buonfrate D; De Wit S; Van Laethem Y; Dauby N
Clin Microbiol Infect; 2021 Jul; 27(7):958-967. PubMed ID: 33813107
[TBL] [Abstract][Full Text] [Related]
36. Early drop of circulating T cells negatively correlates with the protective immune response to Yellow Fever vaccination.
Bovay A; Speiser DE; Fuertes Marraco SA
Hum Vaccin Immunother; 2020 Dec; 16(12):3103-3110. PubMed ID: 32348192
[TBL] [Abstract][Full Text] [Related]
37. Identification of Novel Yellow Fever Class II Epitopes in YF-17D Vaccinees.
Mateus J; Grifoni A; Voic H; Angelo MA; Phillips E; Mallal S; Sidney J; Sette A; Weiskopf D
Viruses; 2020 Nov; 12(11):. PubMed ID: 33198381
[TBL] [Abstract][Full Text] [Related]
38. Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice.
Ma J; Boudewijns R; Sanchez-Felipe L; Mishra N; Vercruysse T; Buh Kum D; Thibaut HJ; Neyts J; Dallmeier K
Emerg Microbes Infect; 2021 Dec; 10(1):2279-2290. PubMed ID: 34792431
[TBL] [Abstract][Full Text] [Related]
39. A Systems Vaccinology Approach Reveals Temporal Transcriptomic Changes of Immune Responses to the Yellow Fever 17D Vaccine.
Hou J; Wang S; Jia M; Li D; Liu Y; Li Z; Zhu H; Xu H; Sun M; Lu L; Zhou Z; Peng H; Zhang Q; Fu S; Liang G; Yao L; Yu X; Carpp LN; Huang Y; McElrath J; Self S; Shao Y
J Immunol; 2017 Aug; 199(4):1476-1489. PubMed ID: 28687661
[TBL] [Abstract][Full Text] [Related]
40. Yellow fever virus 17D envelope and NS3 proteins are major targets of the antiviral T cell response in mice.
van der Most RG; Harrington LE; Giuggio V; Mahar PL; Ahmed R
Virology; 2002 Apr; 296(1):117-24. PubMed ID: 12036323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
